Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

Documenti analoghi

• Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
  di: Marin, B, et al.
  Pubblicazione: (2009)
• Pretreatment CD4 cell slope and progression to AIDS or death in HIV-infected patients initiating antiretroviral therapy--the CASCADE collaboration: a collaboration of 23 cohort studies.
  di: Wolbers, M, et al.
  Pubblicazione: (2010)
• Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy
  di: Sridharan Sudharshan, et al.
  Pubblicazione: (2020-01-01)
• Pulmonary toxoplasmosis in human immunodeficiency virus-infected patients in the era of antiretroviral therapy
  di: Jorge N Velásquez, et al.
  Pubblicazione: (2016-01-01)
• Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
  di: Bhaskaran, K, et al.
  Pubblicazione: (2004)